SEC Form 4 · accession 0000914190-15-000218
NEPHROS INC · NEPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Malcolm C Persen
Director
Period of report
May 12, 2015
Accepted (ET)
May 14, 2015 · 5:08 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001196298
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 12, 2015 | P$0 | 31,160 | — | A | 31,160 | I | By spouse |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Warrants (right to buy)F1 | $0.85 | May 12, 2015 | P | 15,580 | A | May 12, 2015 | May 18, 2020 | Common Stock | 15,580 | 15,580 | I |
| Stock Option (Right to Buy)F2 | $0.79 | holding | — | — | — | — | May 7, 2025 | Common Stock | 56,981 | 56,981 | D |
Explanation of responses
- F1The reported securities have a purchase price of $0.67 per share of Common Stock. In addition, the reporting person received a Warrant to purchase a number of shares of Common Stock equal to 50% of the number of shares of Common Stock otherwise purchased. The reporting person purchased 31,160 shares of Common Stock and was issued related Warrants to acquire up to 50% of the number of shares of Common Stock (i.e., 15,580 Warrants).
- F2On May 7, 2015, the Company granted to Mr. Persen an option to purchase 56,981 shares of common stock of the Company, of which one-third vested immediately upon the grant date, one-third will vest on the first anniversary of the grant date, and the remaining one-third will vest on the second anniversary of the grant date.